The Stockholm stock exchange continued yesterday's rally, climbing in early Tuesday trading. In this morning's news flow, Nibe's report was in line with expectations, Volvo reached a settlement in the US, and Evolution launched a buyback program.

Sentiment remains driven by the rates market and commodities. Geopolitical concerns in the Middle East have pushed oil prices up for a period, which in turn has created renewed inflation fears. Meanwhile, global yields continue to tick upwards.

On Tuesday, oil prices are falling after Donald Trump stated he had postponed a planned attack on Iran. The US is also extending a sanctions waiver allowing the purchase of Russian seaborne oil.

At around 09:24, the OMXS30 index was up 0.60 percent at 3,073.97. Adjusted for dividends, the OMXS30 index rose 0.65 percent. Shares worth approximately SEK 1.9 billion were traded on the Stockholm exchange.

All major industrial sectors are trading higher this morning. Consumer discretionaries saw the best performance with a rise of 2.61 percent.

Among the leading stocks in the OMXS30 index, Evolution rose 11.1 percent while Saab B was up 3.8 percent. The weakest performers were Boliden, down 0.7 percent, and Nibe B, which fell 0.6 percent.

Truck and bus manufacturer Volvo's North American operations have reached a settlement with the CARB authority in the state of California. The settlement will have a negative impact of SEK 1.8 billion on second-quarter operating profit. Volvo rose 0.2 percent.

Live casino developer Evolution's board has decided on a share buyback program of up to EUR 2 billion. The program begins immediately and runs until the 2027 Annual General Meeting. The company announced in March that there will be no dividend for 2025. Evolution surged 11.2 percent.

Private equity firm EQT has been selected by the European Commission and other founding investors as the preferred investment advisor and fund manager for the Scaleup Europe Fund, which has a target size of EUR 5 billion. EQT climbed 2.1 percent.

Heating technology company Nibe reported first-quarter 2026 sales and operating profit in line with analyst expectations. The company expects a stronger second half compared to the first half. Nibe rose 0.6 percent.

Technology trading group Lagercrantz reported EBITA for the fourth quarter of its broken fiscal year (January to March 2026) that beat analyst expectations. The dividend also came in higher than expected, while sales were in line with consensus. Lagercrantz climbed 7.3 percent.

Kopparbergs Bryggeri reported higher earnings for the first quarter compared to the same period last year. Sales rose slightly while pre-tax profit more than tripled. CEO Peter Bronsman stated that the year has started positively and that development is in line with both budget and expectations. The stock rose 1.6 percent.

Immunology company Hansa Biopharma has signed an exclusive licensing agreement with SERB Pharmaceuticals for the development and commercialization of Idefirix in Europe and the MENA region. The total value of the agreement amounts to EUR 115 million. Hansa will initially receive EUR 110 million, equivalent to SEK 1.2 billion, plus an additional EUR 5 million upon full EMA approval for the drug. The stock surged 18.1 percent.

In today's analyst notes, UBS upgraded Intrum to buy from neutral. The target price was significantly lowered to SEK 28 from 54. The stock surged 12.8 percent.

SB1 Markets initiated coverage on Medicover (buy) and Volvo Cars (neutral). Medicover rose 4.5 percent and Volvo Cars 0.3 percent.

Coffee Stain climbed 2.3 percent after Pareto Securities initiated with a buy rating.

Aktiespararna recommends a buy for Vitec, which increased 5.5 percent.